JP2001501442A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501442A5
JP2001501442A5 JP1997514110A JP51411097A JP2001501442A5 JP 2001501442 A5 JP2001501442 A5 JP 2001501442A5 JP 1997514110 A JP1997514110 A JP 1997514110A JP 51411097 A JP51411097 A JP 51411097A JP 2001501442 A5 JP2001501442 A5 JP 2001501442A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997514110A
Other languages
English (en)
Japanese (ja)
Other versions
JP4086315B2 (ja
JP2001501442A (ja
Filing date
Publication date
Priority claimed from GBGB9519928.7A external-priority patent/GB9519928D0/en
Priority claimed from GBGB9612368.2A external-priority patent/GB9612368D0/en
Application filed filed Critical
Priority claimed from PCT/IB1996/001113 external-priority patent/WO1997012972A2/en
Publication of JP2001501442A publication Critical patent/JP2001501442A/ja
Publication of JP2001501442A5 publication Critical patent/JP2001501442A5/ja
Application granted granted Critical
Publication of JP4086315B2 publication Critical patent/JP4086315B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51411097A 1995-09-29 1996-09-30 調節遺伝子およびその使用 Expired - Fee Related JP4086315B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9519928.7A GB9519928D0 (en) 1995-09-29 1995-09-29 Regulated genes and uses thereof
GB9519928.7 1995-09-29
GB9612368.2 1996-06-13
GBGB9612368.2A GB9612368D0 (en) 1996-06-13 1996-06-13 Regulated genes and uses thereof
PCT/IB1996/001113 WO1997012972A2 (en) 1995-09-29 1996-09-30 Regulated genes and uses thereof

Publications (3)

Publication Number Publication Date
JP2001501442A JP2001501442A (ja) 2001-02-06
JP2001501442A5 true JP2001501442A5 (enExample) 2004-09-30
JP4086315B2 JP4086315B2 (ja) 2008-05-14

Family

ID=26307843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51411097A Expired - Fee Related JP4086315B2 (ja) 1995-09-29 1996-09-30 調節遺伝子およびその使用

Country Status (11)

Country Link
US (1) US8383788B2 (enExample)
EP (2) EP1553182B1 (enExample)
JP (1) JP4086315B2 (enExample)
AT (2) ATE290077T1 (enExample)
AU (1) AU7142996A (enExample)
CA (1) CA2230957A1 (enExample)
DE (2) DE69638142D1 (enExample)
ES (2) ES2341864T3 (enExample)
IL (1) IL123649A0 (enExample)
NO (1) NO981353L (enExample)
WO (1) WO1997012972A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US7727761B2 (en) 1995-08-01 2010-06-01 Vegenics Limited Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
DK0848755T4 (da) 1995-09-08 2011-05-23 Genentech Inc VEGF relateret protein
ATE290077T1 (de) 1995-09-29 2005-03-15 Univ Siena Regulierte gene und ihre verwendungen
AU733322B2 (en) 1996-07-15 2001-05-10 Chugai Seiyaku Kabushiki Kaisha Novel VEGF-like factor
DE69734359T2 (de) * 1996-08-23 2006-07-06 Ludwig Institute For Cancer Research Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d)
AU5439998A (en) * 1996-12-06 1998-06-29 Zymogenetics Inc. Vascular endothelial growth factor
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7947472B2 (en) * 1997-12-24 2011-05-24 Vegenics Limited Expression vectors and cell lines expressing vascular endothelial growth factor D
DE19847422C1 (de) * 1998-10-14 2000-01-13 Forschungszentrum Juelich Gmbh Chinese-Hamster-Ovary-Zellen zur Produktion von Proteinen
ATE404668T1 (de) 1998-12-07 2008-08-15 Zymogenetics Inc Wachstumsfaktor-homologe zvegf-3
CA2381985A1 (en) * 1999-08-16 2001-02-22 Universita'degli Studi Di Siena Vegf-d and angiogenic use thereof
JP4981229B2 (ja) 2000-02-25 2012-07-18 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
CA2435503C (en) 2001-01-19 2011-02-22 Ludwig Institute For Cancer Research Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
EP1425580A4 (en) * 2001-07-12 2006-03-29 Ludwig Inst Cancer Res LYMPHATIC ENDOTHELIAL CELLS AND METHODS THEREOF
US20030113324A1 (en) * 2001-10-01 2003-06-19 Kari Alitalo Neuropilin/VEGF-C/VEGFR-3 materials and methods
US20040214766A1 (en) * 2001-10-01 2004-10-28 Kari Alitalo VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
US20040248796A1 (en) * 2003-02-04 2004-12-09 Kari Alitalo VEGF-B and PDGF modulation of stem cells
WO2005011722A2 (en) * 2003-06-12 2005-02-10 Ludwig Institute For Cancer Research Use of vegf-c or vegf-d in reconstructive surgery
WO2005016963A2 (en) * 2003-06-12 2005-02-24 Ludwig Institute For Cancer Research Heparin binding veger-3 ligands
US20060024302A1 (en) 2004-03-05 2006-02-02 Ludwig Institute For Cancer Research Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
ITRM20050367A1 (it) * 2005-07-08 2007-01-09 Univ Siena Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.
EP1919944B1 (en) 2005-08-15 2011-03-23 Vegenics Pty Ltd Modified vegf and pdgf with improved angiogenic properties
WO2008093246A2 (en) 2007-02-02 2008-08-07 Vegenics Limited Vegf receptor antagonist for treating organ transplant alloimmunity and arteriosclerosis
US8571840B2 (en) * 2007-03-28 2013-10-29 Autodesk, Inc. Constraint reduction for dynamic simulation
WO2011154308A1 (en) 2010-06-08 2011-12-15 Proyecto De Biomedicina Cima, S.L. New compositions and cell therapy methods for the treatment of cirrhosis
JP6272781B2 (ja) 2012-01-06 2018-01-31 エンボライン, インコーポレイテッド 統合された塞栓保護デバイス
MY170528A (en) 2013-02-18 2019-08-09 Vegenics Pty Ltd Vegfr-3 ligand binding molecules and uses thereof
CA2995751A1 (en) * 2015-08-25 2017-03-02 Histide Ag Compounds for inducing tissue formation and uses thereof
WO2017032856A2 (en) 2015-08-25 2017-03-02 Histide Ag Compounds for inducing tissue formation and uses thereof
US10617509B2 (en) 2015-12-29 2020-04-14 Emboline, Inc. Multi-access intraprocedural embolic protection device
US11304792B2 (en) 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135983D0 (da) 1983-03-25 1983-03-25 Novo Industri As Maltogen amylaseenzymprodukt og fremgangsmade til dets fremstilling og anvendelse
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5968778A (en) 1989-01-12 1999-10-19 Jurgen Hoppe PDGF-AB, preparation process and pharmaceuticals containing them
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
JP3024311B2 (ja) 1991-10-03 2000-03-21 味の素株式会社 Il−2受容体重鎖に結合するポリペプチド
JPH05271294A (ja) 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするdna
BR9306796A (pt) 1992-07-27 1998-12-08 Pfizer Polipeptidio bloqueador dos canais de cálcio obtido a partir de agelenopsis aperta
DK0751992T3 (da) * 1994-03-08 2006-03-06 Human Genome Sciences Inc Karendotelvækstfaktor 2
US5814464A (en) 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US6645933B1 (en) 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
US6221839B1 (en) 1994-11-14 2001-04-24 Helsinki University Licensing Ltd. Oy FIt4 ligand and methods of use
JPH08185216A (ja) 1994-12-28 1996-07-16 Meidensha Corp 工具姿勢パラメータ設定方法及びロボット制御装置
US5928939A (en) 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
DE69630442T2 (de) 1995-03-02 2004-08-19 Amrad Operations Pty. Ltd., Richmond Ein neuartiger wachstumsfaktor und eine genetische sequenz, die für diesen codiert
EP0873348A4 (en) 1995-06-06 2000-11-08 Human Genome Sciences Inc GROWTH FACTOR 3 OF THE HUMAN VASCULAR ENDOTHELIUM
ATE290077T1 (de) 1995-09-29 2005-03-15 Univ Siena Regulierte gene und ihre verwendungen
AU733322B2 (en) 1996-07-15 2001-05-10 Chugai Seiyaku Kabushiki Kaisha Novel VEGF-like factor
DE69734359T2 (de) 1996-08-23 2006-07-06 Ludwig Institute For Cancer Research Rekombinanter vaskulärer endothelzellen wachstumsfaktor d (vegf-d)
AU5439998A (en) 1996-12-06 1998-06-29 Zymogenetics Inc. Vascular endothelial growth factor
ZA981339B (en) 1997-02-18 1998-10-19 Ludwig Inst Cancer Res Transgenic animal with recombinant vascular endothelial growth factor B (vegf-b) dna and uses thereof
CN1330555A (zh) 1998-12-21 2002-01-09 路德维格癌症研究所 抗截短的vegf-d的抗体及其应用
CA2381985A1 (en) 1999-08-16 2001-02-22 Universita'degli Studi Di Siena Vegf-d and angiogenic use thereof
KR101607347B1 (ko) 2008-02-12 2016-03-29 다우 아그로사이언시즈 엘엘씨 살충 조성물

Similar Documents

Publication Publication Date Title
JP2000500445A5 (enExample)
JP2000500033A5 (enExample)
JP2000500228A5 (enExample)
JP2000500440A5 (enExample)
JPH11500621A5 (enExample)
JP2000500327A5 (enExample)
JPH11511207A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500498A5 (enExample)
JP2000501832A5 (enExample)
JP2000500115A5 (enExample)
JPH11509688A5 (enExample)
JP2000500322A5 (enExample)
JP2000500258A5 (enExample)
JPH11512031A5 (enExample)
JPH11507052A5 (enExample)
JP2000500112A5 (enExample)
JP2000501277A5 (enExample)
JP2000500051A5 (enExample)
JP2000500407A5 (enExample)
JP2000500019A5 (enExample)
JP2001501442A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)